Edgewell Personal Care (NYSE:EPC – Get Free Report) issued its earnings results on Thursday. The company reported $0.78 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.01, FiscalAI reports. The business had revenue of $484.10 million during the quarter, compared to analyst estimates of $479.88 million. Edgewell Personal Care had a positive return on equity of 5.76% and a negative net margin of 4.55%. The firm’s revenue was down 9.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.68 EPS. Edgewell Personal Care updated its FY 2027 guidance to 1.850-2.150 EPS.
Here are the key takeaways from Edgewell Personal Care’s conference call:
- Fiscal 2026 ended with improving momentum: fourth-quarter organic sales rose 3.1%, adjusted gross margin expanded 510 basis points, and full-year adjusted EPS and EBITDA increased. Full-year organic sales growth was modest at 0.3%, while adjusted operating profit declined about 7%.
- Management expects growth across both geographies and all segments in fiscal 2027. It forecast 1%–3% organic sales growth and adjusted EPS of $1.85–$2.15, with share gains, brand investment and innovation supporting the plan; earnings are expected to be heavily weighted to the second half.
- Priority brands are showing stronger traction: Cremo grew more than 50% in the quarter, Hawaiian Tropic gained U.S. share, and U.S. branded razor-and-blade share improved. Edgewell plans to raise advertising and promotion spending to about 13% of sales in fiscal 2027.
- Wet Shave manufacturing consolidation remains a near-term constraint. The project is about six months behind the original timeline, with savings deferred until fiscal 2028; private-label sales are expected to remain pressured in the first half of fiscal 2027 before returning to growth in the second half.
- Inflation and other headwinds temper the outlook. Management cited substantial energy-related inflation and tariff costs, the expiration of FemCare transition-service income, and a higher tax rate; fiscal 2027 adjusted EBITDA is expected to grow about 2% at the midpoint.
Edgewell Personal Care Stock Performance
EPC stock traded down $0.41 on Thursday, hitting $28.74. The company had a trading volume of 918,298 shares, compared to its average volume of 498,385. Edgewell Personal Care has a 12-month low of $15.73 and a 12-month high of $30.36. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of -14.37 and a beta of 0.36. The company has a current ratio of 1.84, a quick ratio of 1.12 and a debt-to-equity ratio of 0.85. The stock’s 50-day simple moving average is $27.85 and its 200 day simple moving average is $24.33.
Edgewell Personal Care Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, January 7th. Stockholders of record on Thursday, December 3rd will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, December 3rd. Edgewell Personal Care’s dividend payout ratio (DPR) is presently -30.00%.
Analysts Set New Price Targets
Several brokerages have weighed in on EPC. Raymond James Financial restated a “market perform” rating on shares of Edgewell Personal Care in a research note on Thursday. Barclays boosted their price objective on Edgewell Personal Care from $28.00 to $29.00 and gave the company an “equal weight” rating in a research note on Friday, August 7th. Royal Bank Of Canada restated an “outperform” rating and issued a $35.00 target price on shares of Edgewell Personal Care in a research note on Tuesday. Weiss Ratings raised Edgewell Personal Care from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, August 25th. Finally, Wells Fargo & Company decreased their price target on shares of Edgewell Personal Care from $32.00 to $30.00 and set an “overweight” rating on the stock in a research note on Monday, October 5th. Three equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $31.50.
Check Out Our Latest Stock Analysis on Edgewell Personal Care
Top Edgewell Personal Care Stories
These are some of the EPC stories that stood out recently:
- Positive Sentiment: Adjusted EPS was $0.78, above the $0.77 consensus and up 50% year over year. Net sales rose 3% (3.1% organically) to $484.1 million, topping estimates of $479.9 million. Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results
- Neutral Sentiment: Fiscal 2027 adjusted EPS guidance is $1.85–$2.15, with a midpoint of $2.00, close to the $1.99 analyst estimate. The company expects growth in organic sales, adjusted EBITDA and adjusted EPS, with revenue of about $2.0 billion. Edgewell fiscal 2027 earnings guidance
- Negative Sentiment: The guidance’s $1.85 low end is below analysts’ estimate, which may be weighing on sentiment despite the quarterly beat. Fiscal 2026 organic sales growth was modest at 0.3%, and full-year adjusted EPS rose 6.6%. Edgewell fiscal 2026 results
About Edgewell Personal Care
Edgewell Personal Care is a global consumer products company focused on personal grooming and sun and skin care. Its products include shaving systems, disposable razors, shaving gels and creams, sunscreens and skin care products, sold through retailers and online channels. Its brand portfolio includes Schick, Wilkinson Sword, Edge, Skintimate, Billie, Banana Boat, Hawaiian Tropic, Bulldog and Jack Black. The company serves consumers in the United States and international markets. Edgewell became an independent public company in 2015 following its separation from Energizer Holdings.
Recommended Stories
- Five stocks we like better than Edgewell Personal Care
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Edgewell Personal Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edgewell Personal Care and related companies with MarketBeat.com's FREE daily email newsletter.
